Impact of the addition of Early Embryo Viability Assessment to morphological evaluation on the accuracy of embryo selection on day 3 or day 5: a retrospective analysis.


Journal

Journal of ovarian research
ISSN: 1757-2215
Titre abrégé: J Ovarian Res
Pays: England
ID NLM: 101474849

Informations de publication

Date de publication:
09 Aug 2019
Historique:
received: 12 12 2018
accepted: 29 07 2019
entrez: 11 8 2019
pubmed: 11 8 2019
medline: 10 1 2020
Statut: epublish

Résumé

In this study we aimed at retrospectively assessing in a homogeneous group of IVF patients whether the addition of Early Embryo Viability Assessment (Eeva™) to standard morphology increases the accuracy of embryo selection in case of double embryo transfer (DET) on day 3 or single embryo transfer (SET) on day 5. Eeva™ is an algorhythm aimed at indicating on day 3, according to morphokinetic parameters observed in the first three days of embryo growth, which embryos are more likely to develop into viable blastocysts and implant. A total number of 328 patients were included in the study; IVF or ICSI were performed and 428 embryos were transferred, either with DET on day 5, or (when at least four top scored embryos were available on day 3) with SET of day 5. Four groups were considered: (a) patients receiving day 3 DET with embryos selected by standard morphology (DET-3 M, n = 106, receiving 212 embryos), (b) patients receiving day 3 DET with embryos selected by morphology plus Eeva™ (DET-3 ME group, n = 48, receiving 96 embryos), (c) patients receiving day 5 SET with a blastocyst selected by standard morphology (SET-5 M group, n = 126, receiving 126 embryos), and (d) patients receiving day 5 SET with a blastocyst selected by morphology plus Eeva™ (SET-5 ME group, n = 48, receiving 48 embryos). Overall, a clinical pregnancy rate of 49.1%, implantation rate of 40%, and ongoing pregnancy rate of 43.6% were observed. The implantation rate was significantly higher in DET-3 ME group than in DET-3 M group (44.8% vs. 30.2%, p < 0.02), whereas it was comparable in groups DET-3 ME, SET-5 M and SET-5 ME. Differently, the ultrasound-verified clinical pregnancy rate and the ongoing pregnancy rate at 12 weeks did not significantly differ in all four groups. Overall, our findings suggest that Eeva™ algorhythm can improve embryo selection accuracy of standard morphology when ET on day 3 is scheduled, leading to a higher implantation rate, but its impact on ongoing pregnancy and live birth needs to be further clarified.

Identifiants

pubmed: 31399038
doi: 10.1186/s13048-019-0547-8
pii: 10.1186/s13048-019-0547-8
pmc: PMC6688364
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

73

Références

Hum Reprod. 2007 Feb;22(2):548-57
pubmed: 17095516
Nat Biotechnol. 2010 Oct;28(10):1115-21
pubmed: 20890283
J Assist Reprod Genet. 2012 Jun;29(6):565-72
pubmed: 22460082
Reprod Biomed Online. 2012 Nov;25(5):474-80
pubmed: 22995750
Fertil Steril. 2013 Aug;100(2):412-9.e5
pubmed: 23721712
Reprod Biomed Online. 2013 Oct;27(4):353-61
pubmed: 23953585
Hum Reprod Update. 2014 Sep-Oct;20(5):617-31
pubmed: 24890606
J Assist Reprod Genet. 2015 Jan;32(1):61-8
pubmed: 25331427
Reprod Biomed Online. 2014 Dec;29(6):729-36
pubmed: 25444507
Fertil Steril. 2015 Feb;103(2):323-32
pubmed: 25527231
Fertil Steril. 2016 Feb;105(2):275-85.e10
pubmed: 26522611
Fertil Steril. 2016 Feb;105(2):369-75.e6
pubmed: 26604069
Ultrasound Obstet Gynecol. 2016 Sep;48(3):289-95
pubmed: 26924732
Hum Reprod. 2016 Nov;31(11):2450-2457
pubmed: 27619774
Fertil Steril. 2017 Mar;107(3):641-648.e2
pubmed: 28108009
Reprod Biomed Online. 2017 Nov;35(5):511-520
pubmed: 28736152
Hum Reprod. 2017 Aug 1;32(8):1598-1603
pubmed: 28854588
Hum Reprod. 2018 May 1;33(5):869-876
pubmed: 29546361

Auteurs

Alberto Revelli (A)

Department of Surgical Sciences, Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, University of Torino, Via Ventimiglia 3, 10126, Torino, Italy. alberto.revelli@unito.it.

Stefano Canosa (S)

Department of Surgical Sciences, Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, University of Torino, Via Ventimiglia 3, 10126, Torino, Italy.

Andrea Carosso (A)

Department of Surgical Sciences, Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, University of Torino, Via Ventimiglia 3, 10126, Torino, Italy.

Claudia Filippini (C)

Department of Surgical Sciences, Clinical statistics, University of Torino, Corso Bramante, 88, Torino, Italy.

Carlotta Paschero (C)

Department of Surgical Sciences, Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, University of Torino, Via Ventimiglia 3, 10126, Torino, Italy.

Gianluca Gennarelli (G)

Department of Surgical Sciences, Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, University of Torino, Via Ventimiglia 3, 10126, Torino, Italy.

Luisa Delle Piane (L)

Department of Surgical Sciences, Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, University of Torino, Via Ventimiglia 3, 10126, Torino, Italy.

Chiara Benedetto (C)

Department of Surgical Sciences, Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, University of Torino, Via Ventimiglia 3, 10126, Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH